Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results

Published:2016-11-08 Issue:3 Volume:143 Page:481-489
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Jia Zhongzhi,Paz-Fumagalli Ricardo,Frey Gregory,Sella David M.,McKinney J. Mark,Wang Weiping

Funder

High-Level Medical Talents Training Project of Changzhou

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-016-2291-4.pdf

Reference34 articles.

1. Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system. Lyon, IARC

2. Brandi G, Venturi M, Pantaleo MA et al (2016) Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: a review of the literature and a long-standing experience of a referral center. Dig Liver Dis 48:231–241

3. Camacho JC, Kokabi N, Xing M et al (2014) Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization. J Vasc Interv Radiol 25:256–265

4. Chaiteerakij R, Schmit GD, Mettler TA et al (2011) Comparison of transarterial radioembolization (Tare) and transarterial chemoembolization (TACE) for the treatment of unresectable intrahepatic cholangiocarcinoma. Gastroenterology 140:S920–S921

5. Chiou YY, Hwang JI, Chou YH et al (2005) Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci 21:304–309

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver-Directed Therapy Combined with Systemic Therapy: Current Status and Future Directions;Seminars in Interventional Radiology;2023-12

2. Intrahepatic cholangiocarcinoma: a dose threshold evaluation in those undergoing transarterial radioembolization;Journal of Gastrointestinal Oncology;2023-10

3. Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?;Cancers;2023-08-23

4. Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience;Cancers;2023-05-03

5. Locoregional Therapy for Intrahepatic Cholangiocarcinoma;Cancers;2023-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3